Table I. Activated mN1IC enhances differentiation of 32D cells in the absence of G-CSF.
32D clone | Percentage of cell typesa |
Total numberd of differentiated cells ×105 | pe | ||
---|---|---|---|---|---|
Blasts | EGb | LGc | |||
rneo3 | |||||
–OHT | 99 ± 1 | 1 ± 1 | 0 ± 0 | 2 ± 2 | |
+OHT | 97 ± 1 | 3 ± 1 | 0 ± 0 | 5 ± 2 | |
rNERTneo12 | |||||
–OHT | 100 ± 0 | 0 ± 0 | 0 ± 0 | 0 ± 0 | |
+OHT | 13 ± 1 | 56 ± 3 | 31 ± 4 | 48 ± 4 | ≤0.001 |
rNERTneo21 | |||||
–OHT | 95 ± 1 | 5 ± 1 | 0 ± 0 | 16 ± 3 | |
+OHT | 53 ± 2 | 44 ± 1 | 3 ± 1 | 42 ± 2 | ≤0.001 |
aCells were cultured in low concentrations of IL-3 (1–10 U IL-3 per ml) for 7 days. Mean values ± SEM of two representative experiments using 2 U IL-3 per ml are shown. The experiment under low IL-3 conditions was repeated nine times yielding virtually identical results.
bEarly granulocytes (promyelocytes and myelocytes).
cLate granulocytes (metamyelocytes and granulocytes).
dCalculated by multiplication of the absolute cell number with the percentage of differentiated cells (EG and LG).
eThe increase in total number of differentiated cells after OHT treatment is statistically significant.